Cellect Biotechnology
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study (NCT03260101) | Cellect Biotechnology | 2018-06-10 |
| Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation (NCT02828878) | Cellect Biotechnology | 2017-01-01 |
Track Cellect Biotechnology automatically
Every clearance here is in the API, with alerts when new ones post.